De- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia
Clinical trial NCT01804985 · COMPLETED
Trial details
- NCT number
- NCT01804985
- Sponsor
- University of Liverpool
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2018-06-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.